AGAP1/AP‐3‐dependent endocytic recycling of M5 muscarinic receptors promotes dopamine release

• Published in: The EMBO journal Vol. 29; no. 16; pp. 2813 - 2826
• Main Authors: Bendor, Jacob, Lizardi‐Ortiz, José E, Westphalen, Robert I, Brandstetter, Markus, Hemmings, Hugh C, Sulzer, David, Flajolet, Marc, Greengard, Paul
• Format: Journal Article
• Language: English
• Published: Chichester, UK John Wiley & Sons, Ltd 18.08.2010; Blackwell Publishing Ltd; Nature Publishing Group
• Subjects: Adaptor Protein Complex 3 - analysis; Adaptor Protein Complex 3 - metabolism; AGAP1; Amino Acid Sequence; Animals; AP‐3; Cells, Cultured; Cellular biology; Corpus Striatum - metabolism; Dopamine; Dopamine - metabolism; endocytic recycling; Endocytosis; Female; Gene expression; GTPase-Activating Proteins - analysis; GTPase-Activating Proteins - metabolism; Membranes; Mice; Mice, Inbred C57BL; Molecular biology; Molecular Sequence Data; muscarinic receptors; Neurons; Neurons - cytology; Neurosciences; Protein Structure, Tertiary; Rats; Rats, Sprague-Dawley; Receptor, Muscarinic M5 - analysis; Receptor, Muscarinic M5 - metabolism; Sequence Alignment
• ISSN: 0261-4189; 1460-2075
• DOI: 10.1038/emboj.2010.154

Of the five mammalian muscarinic acetylcholine (ACh) receptors, M5 is the only subtype expressed in midbrain dopaminergic neurons, where it functions to potentiate dopamine release. We have identified a direct physical interaction between M5 and the AP‐3 adaptor complex regulator AGAP1. This interaction was specific with regard to muscarinic receptor (MR) and AGAP subtypes, and mediated the binding of AP‐3 to M5. Interaction with AGAP1 and activity of AP‐3 were required for the endocytic recycling of M5 in neurons, the lack of which resulted in the downregulation of cell surface receptor density after sustained receptor stimulation. The elimination of AP‐3 or abrogation of AGAP1–M5 interaction in vivo decreased the magnitude of presynaptic M5‐mediated dopamine release potentiation in the striatum. Our study argues for the presence of a previously unknown receptor‐recycling pathway that may underlie mechanisms of G‐protein‐coupled receptor (GPCR) homeostasis. These results also suggest a novel therapeutic target for the treatment of dopaminergic dysfunction. G‐protein‐coupled receptors, such as the M5 muscarinic acetylcholine receptor, undergo rapid internalization and thus desensitization after agonist stimulation. This study identifies a novel molecular mechanism for this internalization step that involves the direct interaction between the AP‐3 adaptor complex regulator AGAP1 and M5 receptors.